prazosin hydrochloride
Sponsors
Vanderbilt University, Brian J Lipworth, US Department of Veterans Affairs, Seattle Institute for Biomedical and Clinical Research, Centre for Addiction and Mental Health
Conditions
Alcohol Use DisordersAllergic RhinitisCannabis DependenceCannabis Use DisorderCombat DisordersDementiaHeadacheHealthy
Phase 1
Treatment of Supine Hypertension in Autonomic Failure
CompletedNCT00223717
Start: 2001-01-31End: 2017-01-31Updated: 2017-10-13
The Effects of Prazosin on Dopamine in Healthy Humans: A PET Pilot Study
CompletedNCT01999530
Start: 2013-11-30End: 2016-08-31Updated: 2019-05-30
Chronic Postconcussive Headache: A Placebo-Controlled Treatment Trial of Prazosin
CompletedNCT02266329
Start: 2016-01-04End: 2023-09-30Updated: 2026-03-30
Phase 4
Differential Adrenoreceptor Mediated Tachyphylaxis and Upregulation
CompletedNCT00487032
Start: 2008-05-31End: 2009-05-31Updated: 2019-04-12
Prazosin and Cerebrospinal Fluid (CSF) Biomarkers in Mild Traumatic Brain Injury (mTBI)
TerminatedNCT03221751
Start: 2016-12-01End: 2023-12-05Updated: 2024-02-26
Reducing Cannabis Overuse With Prazosin
CompletedNCT04721353
Start: 2020-11-09End: 2025-06-01Updated: 2025-06-15
Unknown Phase
Effect of Prazosin on Neurophysiology and Cognition in Post-Traumatic Stress Disorder (PTSD)
WithdrawnNCT00890643
Start: 2009-12-31End: 2011-09-30Updated: 2013-09-23
Augmentation Trial of Prazosin for Post-Traumatic Stress Disorder (PTSD)
CompletedNCT00990106
Start: 2009-09-30End: 2013-03-31Updated: 2018-05-23
Prazosin Augmentation of Outpatient Treatment of Alcohol Use Disorders in Active Duty Soldiers With and Without PTSD
CompletedNCT02226367
Start: 2015-01-31End: 2018-10-20Updated: 2023-02-03